The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Janikashvili, Nona ^a   Bonnotte, Bernard ^a   Katsanis, Emmanuel ^b   Larmonier, Nicolas ^b  

^a Chu   (France)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 7 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; SMAD PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR ANTIGEN;

CANCER CELL; CARCINOGENESIS; CELL ACTIVATION; CELL COMMUNICATION; CELL EXPANSION; CELL MATURATION; CELL MIGRATION; CELLULAR IMMUNITY; CYTOKINE RELEASE; DENDRITIC CELL; EFFECTOR CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INTRACELLULAR SIGNALING; LYMPHOCYTE ACTIVATION; MEMORY CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; REGULATORY T LYMPHOCYTE; REVIEW; TH2 CELL; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CLONAL ANERGY; DISEASE COURSE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR ESCAPE;

ANIMALS; ANTIGENS, NEOPLASM; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; CLONAL ANERGY; DENDRITIC CELLS; DISEASE PROGRESSION; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; NEOPLASMS; T-LYMPHOCYTES, REGULATORY; TUMOR ESCAPE;

EID: 84855167728     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/430394     Document Type: Review

References (227)

1. Staveley-O'Carroll K., Sotomayor E., Montgomery J., Borrello I., Hwang L., Fein S., Pardoll D., Levitsky H., Induction of antigen-specific T cell anergy: an early event in the course of tumor progression Proceedings of the National Academy of Sciences of the United States of America 1998 95 3 1178 1183 (Pubitemid 28124932)
2. Smyth M. J., Godfrey D. I., Trapani J. A., A fresh look at tumor immunosurveillance and immunotherapy Nature Immunology 2001 2 4 293 299 (Pubitemid 33706339)
3. Feinberg M. B., Silvestri G., T(S) cells and immune tolerance induction: a regulatory renaissance? Nature Immunology 2002 3 3 215 217 (Pubitemid 34213422)
4. Pardoll D., Does the immune system see tumors as foreign or self? Annual Review of Immunology 2003 21 807 839 (Pubitemid 37174548)
5. Zitvogel L., Tesniere A., Kroemer G., Cancer despite immunosurveillance: immunoselection and immunosubversion Nature Reviews Immunology 2006 6 10 715 727 (Pubitemid 44453458)
6. Khong H. T., Restifo N. P., Natural selection of tumor variants in the generation of tumor escape phenotypes Nature Immunology 2002 3 11 999 1005 (Pubitemid 35363649)
7. Restifo N. P., Esquivel F., Kawakami Y., Yewdell J. W., Mule J. J., Rosenberg S. A., Bennink J. R., Identification of human cancers deficient in antigen processing Journal of Experimental Medicine 1993 177 2 265 272 (Pubitemid 23117076)
8. Hicklin D. J., Wang Z., Arienti F., Rivoltini L., Parmiani G., Ferrone S., 2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma Journal of Clinical Investigation 1998 101 12 2720 2729 (Pubitemid 28294581)
9. Restifo N. P., Marincola F. M., Kawakami Y., Taubenberger J., Yannelli J. R., Rosenberg S. A., Loss of functional beta2-microglobulin in metastatic melanomas from five patients receiving immunotherapy Journal of the National Cancer Institute 1996 88 2 100 108
10. Garrido F., Ruiz-Cabello F., Cabrera T., Pérez-Villar J. J., Lpez-Botet M., Duggan-Keen M., Stern P. L., Implications for immunosurveillance of altered HLA class I phenotypes in human tumours Immunology Today 1997 18 2 89 95 (Pubitemid 27107103)
11. Rabinovich G. A., Gabrilovich D., Sotomayor E. M., Immunosuppressive strategies that are mediated by tumor cells Annual Review of Immunology 2007 25 267 296 (Pubitemid 46697910)
12. Lu B., Finn O. J., T-cell death and cancer immune tolerance Cell Death and Differentiation 2008 15 1 70 79 (Pubitemid 350286174)
13. Vucic D., Fairbrother W. J., The inhibitor of apoptosis proteins as therapeutic targets in cancer Clinical Cancer Research 2007 13 20 5995 6000 (Pubitemid 350075054)
14. Rampino N., Yamamoto H., Ionov Y., Li Y., Sawai H., Reed J. C., Perucho M., Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype Science 1997 275 5302 967 969 (Pubitemid 27087710)
15. Medema J. P., de Jong J., Peltenburg L. T. C., Verdegaal E. M. E., Gorter A., Bres S. A., Franken K. L. M. C., Hahne M., Albar J. P., Melief C. J. M., Offringa R., Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors Proceedings of the National Academy of Sciences of the United States of America 2001 98 20 11515 11520 (Pubitemid 32928760)
16. Vicari A. P., Caux C., Trinchieri G., Tumour escape from immune surveillance through dendritic cell inactivation Seminars in Cancer Biology 2002 12 1 33 42 (Pubitemid 34087896)
17. Nagaraj S., Gabrilovich D. I., Tumor escape mechanism governed by myeloid-derived suppressor cells Cancer Research 2008 68 8 2561 2563 (Pubitemid 351556251)
18. Gabrilovich D., Mechanisms and functional significance of tumour-induced dendritic-cell defects Nature Reviews Immunology 2004 4 12 941 952 (Pubitemid 39620069)
19. Zou W., Regulatory T cells, tumour immunity and immunotherapy Nature Reviews Immunology 2006 6 4 295 307
20. Fricke I., Gabrilovich D. I., Dendritic cells and tumor microenvironment: a dangerous liaison Immunological Investigations 2006 35 3-4 459 483 (Pubitemid 44266783)
21. Kusmartsev S., Gabrilovich D. I., Role of immature myeloid cells in mechanisms of immune evasion in cancer Cancer Immunology, Immunotherapy 2006 55 3 237 245 (Pubitemid 41683212)
22. Terme M., Chaput N., Combadiere B., Averil M., Ohteki T., Zitvogel L., Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells Journal of Immunology 2008 180 7 4679 4686
23. Shevach E. M., Mechanisms of Foxp3+ T regulatory cell-mediated suppression Immunity 2009 30 5 636 645
24. Antony P. A., Piccirillo C. A., Akpinarli A., Finkelstein S. E., Speiss P. J., Surman D. R., Palmer D. C., Chan C. C., Klebanoff C. A., Overwijk W. W., Rosenberg S. A., Restifo N. P., CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells Journal of Immunology 2005 174 5 2591 2601 (Pubitemid 40279672)
25. Piccirillo C. A., Shevach E. M., Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells Journal of Immunology 2001 167 3 1137 1140 (Pubitemid 32703105)
26. Almand B., Clark J. I., Nikitina E., van Beynen J., English N. R., Knight S. C., Carbone D. P., Gabrilovich D. I., Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer Journal of Immunology 2001 166 1 678 689 (Pubitemid 32038493)
27. Banchereau J., Steinman R. M., Dendritic cells and the control of immunity Nature 1998 392 6673 245 252 (Pubitemid 28155090)
28. Adema G. J., Dendritic cells from bench to bedside and back Immunology letters 2009 122 2 128 130
29. Steinman R. M., Banchereau J., Taking dendritic cells into medicine Nature 2007 449 7161 419 426 (Pubitemid 47509552)
30. Steinman R. M., Some interfaces of dendritic cell biology APMIS 2003 111 7-8 675 697 (Pubitemid 37130017)
31. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y. J., Pulendran B., Palucka K., Immunobiology of dendritic cells Annual Review of Immunology 2000 18 767 811 (Pubitemid 30365397)
32. Palucka A. K., Ueno H., Fay J., Banchereau J., Dendritic cells: a critical player in cancer therapy? Journal of Immunotherapy 2008 31 9 793 805
33. Janikashvili N., Larmonier N., Katsanis E., Personalized dendritic cell-based tumor immunotherapy Immunotherapy 2010 2 1 57 68
34. Fraszczak J., Trad M., Janikashvili N., Cathelin D., Lakomy D., Granci V., Morizot A., Audia S., Micheau O., Lagrost L., Katsanis E., Solary E., Larmonier N., Bonnotte B., Peroxynitrite-dependent killing of cancer cells and presentation of released tumor antigens by activated dendritic cells Journal of Immunology 2010 184 4 1876 1884
35. Larmonier N., Fraszczak J., Lakomy D., Bonnotte B., Katsanis E., Killer dendritic cells and their potential for cancer immunotherapy Cancer Immunology, Immunotherapy 2010 59 1 1 11
36. Melief C. J. M., Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct priming? European Journal of Immunology 2003 33 10 2645 2654 (Pubitemid 37337130)
37. Lin A., Schildknecht A., Nguyen L. T., Ohashi P. S., Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth Immunology Letters 2010 127 2 77 84
38. Conroy H., Marshall N. A., Mills K. H. G., TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours Oncogene 2008 27 2 168 180
39. Steinman R. M., Hawiger D., Nussenzweig M. C., Tolerogenic dendritic cells Annual Review of Immunology 2003 21 685 711 (Pubitemid 37174545)
40. Steinman R. M., Hawiger D., Liu K., Bonifaz L., Bonnyay D., Mahnke K., Iyoda T., Ravetch J., Dhodapkar M., Inaba K., Nussenzweig M., Dendritic cell function in vivo during the steady state: a role in peripheral tolerance Annals of the New York Academy of Sciences 2003 987 15 25 (Pubitemid 36584003)
41. Kushwah R., Wu J., Oliver J. R., Jiang G., Zhang J., Siminovitch K. A., Hu J., Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg European Journal of Immunology 2010 40 4 1022 1035
42. Rutella S., Danese S., Leone G., Tolerogenic dendritic cells: cytokine modulation comes of age Blood 2006 108 5 1435 1440 (Pubitemid 44316106)
43. Hubert P., Jacobs N., Caberg J. H., Boniver J., Delvenne P., The cross-talk between dendritic and regulatory T cells: good or evil? Journal of Leukocyte Biology 2007 82 4 781 794 (Pubitemid 47511037)
44. Mahnke K., Bedke T., Enk A. H., Regulatory conversation between antigen presenting cells and regulatory T cells enhance immune suppression Cellular Immunology 2007 250 1-2 1 13
45. Mahnke K., Knop J., Enk A. H., Induction of tolerogenic DCs: You are what you eat Trends in Immunology 2003 24 12 646 651 (Pubitemid 37485914)
46. Jonuleit H., Schmitt E., Schuler G., Knop J., Enk A. H., Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells Journal of Experimental Medicine 2000 192 9 1213 1222
47. Kusmartsev S., Gabrilovich D. I., Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer Cancer and Metastasis Reviews 2006 25 3 323 331 (Pubitemid 44922353)
48. Larmonier N., Marron M., Zeng Y., Cantrell J., Romanoski A., Sepassi M., Thompson S., Chen X., Andreansky S., Katsanis E., Tumor-derived CD4+CD25+ regulatory T cell suppression of dendritic cell function involves TGF- and IL-10 Cancer Immunology, Immunotherapy 2007 56 1 48 59 (Pubitemid 44812446)
49. Chaux P., Favre N., Bonnotte B., Moutet M., Martin M., Martin F., Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expressiona role in the immune tolerance to antigenic tumors Advances in Experimental Medicine and Biology 1997 417 525 528
50. Monti P., Leone B. E., Zerbi A., Balzano G., Cainarca S., Sordi V., Pontillo M., Mercalli A., di Carlo V., Allavena P., Piemonti L., Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell Journal of Immunology 2004 172 12 7341 7349 (Pubitemid 38747594)
51. Norian L. A., Rodriguez P. C., O'Mara L. A., Zabaleta J., Ochoa A. C., Cella M., Allen P. M., Tumor-Infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-Arginine metabolism Cancer Research 2009 69 7 3086 3094
52. Gabrilovich D. I., Chen H. L., Girgis K. R., Cunningham H. T., Meny G. M., Nadaf S., Kavanaugh D., Carbone D. P., Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells Nature Medicine 1996 2 10 1096 1103 (Pubitemid 26338628)
53. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J. V., Steinman R. M., Nussenzweig M. C., Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo Journal of Experimental Medicine 2001 194 6 769 779 (Pubitemid 32983013)
54. Melani C., Chiodoni C., Forni G., Colombo M. P., Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity Blood 2003 102 6 2138 2145 (Pubitemid 37122391)
55. Maldonado R. A., von Andrian U. H., How tolerogenic dendritic cells induce regulatory T cells Advances in Immunology 2010 108 111 165
56. Yamazaki S., Steinman R. M., Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells Journal of Dermatological Science 2009 54 2 69 75
57. Yamazaki S., Inaba K., Tarbell K. V., Steinman R. M., Dendritic cells expand antigen-specific Foxp3+CD25 +CD4+ regulatory T cells including suppressors of alloreactivity Immunological Reviews 2006 212 314 329 (Pubitemid 44116717)
58. Mahnke K., Qian Y., Knop J., Enk A. H., Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells Blood 2003 101 12 4862 4869 (Pubitemid 36857748)
59. Zhang M., Tang H., Guo Z., An H., Zhu X., Song W., Guo J., Huang X., Chen T., Wang J., Cao X., Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells Nature Immunology 2004 5 11 1124 1133 (Pubitemid 39549626)
60. Aspord C., Pedroza-Gonzalez A., Gallegos M., Tindle S., Burton E. C., Su D., Marches F., Banchereau J., Palucka A. K., Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development Journal of Experimental Medicine 2007 204 5 1037 1047 (Pubitemid 46798148)
61. Stoitzner P., Green L. K., Jung J. Y., Price K. M., Atarea H., Kivell B., Ronchese F., Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells Cancer Immunology, Immunotherapy 2008 57 11 1665 1673
62. Cheng C., Qu Q. X., Shen Y., Lv Y. T., Zhu Y. B., Zhang X. G., Huang J. A., Overexpression of B7-H4 in tumor infiltrated dendritic cells Journal of Immunoassay and Immunochemistry 2011 32 4 353 364
63. Chaux P., Favre N., Martin M., Martin F., Tumor-infiltrating dendritic cells are defective in their antigen- presenting function and inducible B7 expression in rats International Journal of Cancer 1997 72 4 619 624 (Pubitemid 27356163)
64. Bonnotte B., Crittenden M., Larmonier N., Gough M., Vile R. G., MIP-3 transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity Journal of Immunology 2004 173 8 4929 4935 (Pubitemid 39387774)
65. Chaux P., Moutet M., Faivre J., Martin F., Martin M., Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation Laboratory Investigation 1996 74 5 975 983 (Pubitemid 26152665)
66. Sharma M. D., Baban B., Chandler P., Hou D. Y., Singh N., Yagita H., Azuma M., Blazar B. R., Mellor A. L., Munn D. H., Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase Journal of Clinical Investigation 2007 117 9 2570 2582 (Pubitemid 47494358)
67. Hartmann E., Wollenberg B., Rothenfusser S., Wagner M., Wellisch D., Mack B., Giese T., Gires O., Endres S., Hartmann G., Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer Cancer Research 2003 63 19 6478 6487 (Pubitemid 37255200)
68. Zoul W., Machelon V., Coulomb-L'Hermin A., Borvakz J., Nome F., Isaeva T., Wei S., Krzysieks R., Durand-Gasselin I., Gordon A., Pustilnik T., Curiel D. T., Galanaud P., Capron F., Emilie D., Curiel T. J., Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells Nature Medicine 2001 7 12 1339 1346 (Pubitemid 34007939)
69. Charles J., di Domizio J., Salameire D., Bendriss-Vermare N., Aspord C., Muhammad R., Lefebvre C., Plumas J., Leccia M. T., Chaperot L., Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor Journal of Investigative Dermatology 2010 130 6 1646 1656
70. Munn D. H., Mellor A. L., Indoleamine 2,3-dioxygenase and tumor-induced tolerance Journal of Clinical Investigation 2007 117 5 1147 1154 (Pubitemid 46718399)
71. Munn D. H., Sharma M. D., Hou D., Baban B., Lee J. R., Antonia S. J., Messina J. L., Chandler P., Koni P. A., Mellor A. L., Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes Journal of Clinical Investigation 2004 114 2 280 290 (Pubitemid 39071633)
72. Weinlich G., Murr C., Richardsen L., Winkler C., Fuchs D., Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients Dermatology 2007 214 1 8 14 (Pubitemid 46032994)
73. Brody J. R., Costantino C. L., Berger A. C., Sato T., Lisanti M. P., Yeo C. J., Emmons R. V., Witkiewicz A. K., Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival Cell Cycle 2009 8 12 1930 1934
74. Lee J. R., Dalton R. R., Messina J. L., Sharma M. D., Smith D. M., Burgess R. E., Mazzella F., Antonia S. J., Mellor A. L., Munn D. H., Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma Laboratory Investigation 2003 83 10 1457 1466 (Pubitemid 37267829)
75. Witkiewicz A., Williams T. K., Cozzitorto J., Durkan B., Showalter S. L., Yeo C. J., Brody J. R., Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection Journal of the American College of Surgeons 2008 206 5 849 854
76. Okamoto A., Nikaido T., Ochiai K., Takakura S., Saito M., Aoki Y., Ishii N., Yanaihara N., Yamada K., Takikawa O., Kawaguchi R., Isonishi S., Tanaka T., Urashima M., Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells Clinical Cancer Research 2005 11 16 6030 6039 (Pubitemid 41170335)
77. Brandacher G., Perathoner A., Ladurner R., Schneeberger S., Obrist P., Winkler C., Werner E. R., Werner-Felmayer G., Weiss H. G., Gbel G., Margreiter R., Knigsrainer A., Fuchs D., Amberger A., Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells Clinical Cancer Research 2006 12 4 1144 1151 (Pubitemid 43342502)
78. Huang A., Fuchs D., Widner B., Glover C., Henderson D. C., Allen-Mersh T. G., Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer British Journal of Cancer 2002 86 11 1691 1696 (Pubitemid 34712909)
79. Astigiano S., Morandi B., Costa R., Mastracci L., D'Agostino A., Ratto G. B., Melioli G., Frumento G., Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer Neoplasia 2005 7 4 390 396 (Pubitemid 40664228)
80. Riesenberg R., Weiler C., Spring O., Eder M., Buchner A., Popp T., Castro M., Kammerer R., Takikawa O., Hatz R. A., Stief C. G., Hofstetter A., Zimmermann W., Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma Clinical Cancer Research 2007 13 23 6993 7002 (Pubitemid 350276880)
81. Yao X., Qian C. N., Zhang Z. F., Tan M. H., Kort E. J., Yang X. J., Resau J. H., Teh B. T., Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications Clinical Cancer Research 2007 13 1 161 169 (Pubitemid 46121865)
82. Conejo-Garcia J. R., Benencia F., Courreges M. C., Kang E., Mohamed-Hadley A., Buckanovich R. J., Holtz D. O., Jenkins A., Na H., Zhang L., Wagner D. S., Katsaros D., Caroll R., Coukos G., Tumor-infiltrating dendritic cell precursors recruited by a -defensin contribute to vasculogenesis under the influence of Vegf-A Nature Medicine 2004 10 9 950 958 (Pubitemid 39273736)
83. Curiel T. J., Cheng P., Mottram P., Alvarez X., Moons L., Evdemon-Hogan M., Wei S., Zou L., Kryczek I., Hoyle G., Lackner A., Carmeliet P., Zou W., Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer Cancer Research 2004 64 16 5535 5538 (Pubitemid 39095544)
84. Vicari A. P., Vanbervliet B., Massacrier C., Chiodoni C., Vaure C., At-Yahia S., Dercamp C., Matsos F., Reynard O., Taverne C., Merle P., Colombo M. P., O'Garra A., Trinchieri G., Caux C., In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunity Novartis Foundation Symposium 2004 256 241 254
85. Jung S., Unutmaz D., Wong P., Sano G. I., De Los Santos K., Sparwasser T., Wu S., Vuthoori S., Ko K., Zavala F., Pamer E. G., Littman D. R., Lang R. A., In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens Immunity 2002 17 2 211 220 (Pubitemid 35245963)
86. Restifo N. P., Kawakami Y., Marincola F., Shamamian P., Taggarse A., Esquivel F., Rosenberg S. A., Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I Journal of Immunotherapy 1993 14 3 182 190 (Pubitemid 23319206)
87. Cheng F., Wang H. W., Cuenca A., Huang M., Ghansah T., Brayer J., Kerr W. G., Takeda K., Akira S., Schoenberger S. P., Yu H., Jove R., Sotomayor E. M., A critical role for Stat3 signaling in immune tolerance Immunity 2003 19 3 425 436 (Pubitemid 37153418)
88. Ueno H., Klechevsky E., Morita R., Aspord C., Cao T., Matsui T., di Pucchio T., Connolly J., Fay J. W., Pascual V., Palucka A. K., Banchereau J., Dendritic cell subsets in health and disease Immunological Reviews 2007 219 1 118 142 (Pubitemid 47393528)
89. Bromberg J. F., Wrzeszczynska M. H., Devgan G., Zhao Y., Pestell R. G., Albanese C., Darnell J. E., Stat3 as an oncogene Cell 1999 98 3 295 303 (Pubitemid 29380565)
90. Wang T., Niu G., Kortylewski M., Burdelya L., Shain K., Zhang S., Bhattacharya R., Gabrilovich D., Heller R., Coppola D., Dalton W., Jove R., Pardoll D., Yu H., Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells Nature Medicine 2004 10 1 48 54 (Pubitemid 38524698)
91. Nefedova Y., Huang M., Kusmartsev S., Bhattacharya R., Cheng P., Salup R., Jove R., Gabrilovich D., Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer Journal of Immunology 2004 172 1 464 474 (Pubitemid 38020502)
92. Park S. J., Nakagawa T., Kitamura H., Atsumi T., Kamon H., Sawa S. I., Kamimura D., Ueda N., Iwakura Y., Ishihara K., Murakami M., Hirano T., IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation Journal of Immunology 2004 173 6 3844 3854 (Pubitemid 39280747)
93. Nefedova Y., Cheng P., Alsina M., Dalton W. S., Gabrilovich D. I., Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines Blood 2004 103 9 3503 3510 (Pubitemid 38525684)
94. Nefedova Y., Gabrilovich D. I., Targeting of Jak/STAT pathway in antigen presenting cells in cancer Current Cancer Drug Targets 2007 7 1 71 77 (Pubitemid 46345509)
95. Cheng P., Zhou J., Gabrilovich D., Regulation of dendritic cell differentiation and function by Notch and Wnt pathways Immunological Reviews 2010 234 1 105 119
96. Yu H., Kortylewski M., Pardoll D., Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment Nature Reviews Immunology 2007 7 1 41 51 (Pubitemid 46020826)
97. Yu H., Pardoll D., Jove R., STATs in cancer inflammation and immunity: a leading role for STAT3 Nature Reviews Cancer 2009 9 11 798 809
98. Kortylewski M., Kujawski M., Wang T., Wei S., Zhang S., Pilon-Thomas S., Niu G., Kay H., Mulé J., Kerr W. G., Jove R., Pardoll D., Yu H., Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity Nature Medicine 2005 11 12 1314 1321 (Pubitemid 41752912)
99. Burdelya L., Kujawski M., Niu G., Zhong B., Wang T., Zhang S., Kortylewski M., Shain K., Kay H., Djeu J., Dalton W., Pardoll D., Wei S., Yu H., Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects Journal of Immunology 2005 174 7 3925 3931 (Pubitemid 40395966)
100. Evel-Kabler K., Song X. T., Aldrich M., Huang X. F., Chen S. Y., SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling Journal of Clinical Investigation 2006 116 1 90 100 (Pubitemid 43121794)
101. Shevach E. M., CD4+CD25+ suppressor T cells: more questions than answers Nature Reviews Immunology 2002 2 6 389 400 (Pubitemid 37328746)
102. Sakaguchi S., Regulatory T cells: key controllers of immunologic self-tolerance Cell 2000 101 5 455 458
103. Sakaguchi S., Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses Annual Review of Immunology 2004 22 531 562 (Pubitemid 38680433)
104. Suri-Payer E., Amar A. Z., Thornton A. M., Shevach E. M., CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells Journal of Immunology 1998 160 3 1212 1218 (Pubitemid 28093417)
105. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M., Immunologic self-tolerance maintained by activated T cells expressing IL- 2 receptor -chains (CD25): breakdown of a single mechanism of self- tolerance causes various autoimmune diseases Journal of Immunology 1995 155 3 1151 1164
106. Sakaguchi S., Miyara M., Costantino C. M., Hafler D. A., FOXP3 + regulatory T cells in the human immune system Nature Reviews Immunology 2010 10 7 490 500
107. Nishikawa H., Sakaguchi S., Regulatory T cells in tumor immunity International Journal of Cancer 2010 127 4 759 767
108. Sakaguchi S., Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T., Regulatory T cells: how do they suppress immune responses? International Immunology 2009 21 10 1105 1111
109. Belkaid Y., Piccirillo C. A., Mendez S., Shevach E. M., Sacks D. L., CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity Nature 2002 420 6915 502 507 (Pubitemid 35477041)
110. Tran D. Q., Shevach E. M., Therapeutic potential of FOXP3+ regulatory T cells and their interactions with dendritic cells Human Immunology 2009 70 5 294 299
111. Sakaguchi S., Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self Nature Immunology 2005 6 4 345 352 (Pubitemid 41716771)
112. Fontenot J. D., Rudensky A. Y., A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 Nature Immunology 2005 6 4 331 337 (Pubitemid 41716769)
113. Liu W., Putnam A. L., Xu-Yu Z., Szot G. L., Lee M. R., Zhu S., Gottlieb P. A., Kapranov P., Gingeras T. R., De S. G. B. F., Clayberger C., Soper D. M., Ziegler S. F., Bluestone J. A., CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells Journal of Experimental Medicine 2006 203 7 1701 1711 (Pubitemid 44036276)
114. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., Solomon M., Selby W., Alexander S. I., Nanan R., Kelleher A., De S. G. B. F., Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells Journal of Experimental Medicine 2006 203 7 1693 1700 (Pubitemid 44036275)
115. Simonetta F., Chiali A., Cordier C., Urrutia A., Girault I., Bloquet S., Tanchot C., Bourgeois C., Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells European Journal of Immunology 2010 40 9 2528 2538
116. Borsellino G., Kleinewietfeld M., di Mitri D., Sternjak A., Diamantini A., Giometto R., Hpner S., Centonze D., Bernardi G., Dell'Acqua M. L., Rossini P. M., Battistini L., Rtzschke O., Falk K., Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression Blood 2007 110 4 1225 1232 (Pubitemid 47281420)
117. Deaglio S., Dwyer K. M., Gao W., Friedman D., Usheva A., Erat A., Chen J. F., Enjyoji K., Linden J., Oukka M., Kuchroo V. K., Strom T. B., Robson S. C., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression Journal of Experimental Medicine 2007 204 6 1257 1265 (Pubitemid 46919862)
118. Fontenot J. D., Gavin M. A., Rudensky A. Y., Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nature Immunology 2003 4 4 330 336 (Pubitemid 36432314)
119. Fontenot J. D., Rasmussen J. P., Williams L. M., Dooley J. L., Farr A. G., Rudensky A. Y., Regulatory T cell lineage specification by the forkhead transcription factor Foxp3 Immunity 2005 22 3 329 341 (Pubitemid 40387475)
120. Kronenberg M., Rudensky A., Regulation of immunity by self-reactive T cells Nature 2005 435 7042 598 604 (Pubitemid 40825499)
121. Hori S., Nomura T., Sakaguchi S., Control of regulatory T cell development by the transcription factor Foxp3 Science 2003 299 5609 1057 1061 (Pubitemid 36222930)
122. Asano M., Toda M., Sakaguchi N., Sakaguchi S., Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation Journal of Experimental Medicine 1996 184 2 387 396 (Pubitemid 26324092)
123. Bennett C. L., Christie J., Ramsdell F., Brunkow M. E., Ferguson P. J., Whitesell L., Kelly T. E., Saulsbury F. T., Chance P. F., Ochs H. D., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 Nature Genetics 2001 27 1 20 21 (Pubitemid 32044513)
124. Brunkow M. E., Jeffery E. W., Hjerrild K. A., Paeper B., Clark L. B., Yasayko S. A., Wilkinson J. E., Galas D., Ziegler S. F., Ramsdell F., Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse Nature Genetics 2001 27 1 68 73 (Pubitemid 32044521)
125. Sakaguchi S., Wing K., Miyara M., Regulatory T cellsa brief history and perspective European Journal of Immunology 2007 37 supplement 1 S116 S123
126. Valzasina B., Piconese S., Guiducci C., Colombo M. P., Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent Cancer Research 2006 66 8 4488 4495
127. Curiel T. J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J. R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M. L., Knutson K. L., Chen L., Zou W., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nature Medicine 2004 10 9 942 949 (Pubitemid 39273735)
128. Janikashvili N., LaCasse C. J., Larmonier C., Trad M., Herrell A., Bustamante S., Bonnotte B., Har-Noy M., Larmonier N., Katsanis E., Allogeneic effector/memory Th-1 cells impair FoxP3+ regulatory T lymphocytes and synergize with chaperone-rich cell lysate vaccine to treat leukemia Blood 2011 117 5 1555 1564
129. Nicchitta C. V., Biochemical, cell biological and immunological issues surrounding the endoplasmic reticulum chaperone GRP94/gp96 Current Opinion in Immunology 1998 10 1 103 109 (Pubitemid 28112087)
130. Shevach E. M., From vanilla to 28 flavors: multiple varieties of T regulatory cells Immunity 2006 25 2 195 201 (Pubitemid 44224153)
131. Shevach E. M., DiPaolo R. A., Andersson J., Zhao D. M., Stephens G. L., Thornton A. M., The lifestyle of naturally occurring CD4+CD25 +Foxp3+ regulatory T cells Immunological Reviews 2006 212 60 73 (Pubitemid 44116700)
132. Shevach E. M., Stephens G. L., The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nature Reviews Immunology 2006 6 8 613 618 (Pubitemid 44134094)
133. Geng S., Yu Y., Kang Y., Pavlakis G., Jin H., Li J., Hu Y., Hu W., Wang S., Wang B., Efficient induction of CD25-iTreg by co-immunization requires strongly antigenic epitopes for T cells BMC Immunology 2011 12 27
134. Annacker O., Pimenta-Araujo R., Burlen-Defranoux O., Barbosa T. C., Cumano A., Bandeira A., CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-101 Journal of Immunology 2001 166 5 3008 3018 (Pubitemid 33117296)
135. Lehmann J., Huehn J., de la Rosa M., Maszyna F., Kretschmer U., Krenn V., Brunner M., Scheffold A., Hamann A., Expression of the integrin E 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells Proceedings of the National Academy of Sciences of the United States of America 2002 99 20 13031
136. Zelenay S., Lopes-Carvalho T., Caramalho I., Moraes-Fontes M. F., Rebelo M., Demengeot J., Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion Proceedings of the National Academy of Sciences of the United States of America 2005 102 11 4091 4096 (Pubitemid 40388560)
137. Nakamura K., Kitani A., Fuss I., Pedersen A., Harada N., Nawata H., Strober W., TGF- 1 plays an important role in the mechanism of CD4 +CD25+ regulatory T cell activity in both humans and mice Journal of Immunology 2004 172 2 834 842 (Pubitemid 38113739)
138. Nakamura K., Kitani A., Strober W., Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor Journal of Experimental Medicine 2001 194 5 629 644 (Pubitemid 32844773)
139. Piccirillo C. A., Letterio J. J., Thornton A. M., McHugh R. S., Mamura M., Mizuhara H., Shevach E. M., CD4+CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factor 1 production and responsiveness Journal of Experimental Medicine 2002 196 2 237 245 (Pubitemid 34787513)
140. Thornton A. M., Shevach E. M., CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production Journal of Experimental Medicine 1998 188 2 287 296 (Pubitemid 28357757)
141. Asseman C., Mauze S., Leach M. W., Coffman R. L., Powrie F., An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation Journal of Experimental Medicine 1999 190 7 995 1004
142. Collison L. W., Workman C. J., Kuo T. T., Boyd K., Wang Y., Vignali K. M., Cross R., Sehy D., Blumberg R. S., Vignali D. A. A., The inhibitory cytokine IL-35 contributes to regulatory T-cell function Nature 2007 450 7169 566 569 (Pubitemid 350190247)
143. Read S., Malmstrm V., Powrie F., Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation Journal of Experimental Medicine 2000 192 2 295 302 (Pubitemid 30470312)
144. Cederbom L., Hall H., Ivars F., CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells European Journal of Immunology 2000 30 6 1538 1543 (Pubitemid 30342794)
145. Bopp T., Becker C., Klein M., Klein-Heling S., Palmetshofer A., Serfling E., Heib V., Becker M., Kubach J., Schmitt S., Stoll S., Schild H., Staege M. S., Stassen M., Jonuleit H., Schmitt E., Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression Journal of Experimental Medicine 2007 204 6 1303 1310 (Pubitemid 46919868)
146. Gondek D. C., Lu L. F., Quezada S. A., Sakaguchi S., Noelle R. J., Cutting edge: contact-mediated suppression by CD4+CD25 + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism Journal of Immunology 2005 174 4 1783 1786 (Pubitemid 40223916)
147. Grossman W. J., Verbsky J. W., Barchet W., Colonna M., Atkinson J. P., Ley T. J., Human T regulatory cells can use the perforin pathway to cause autologous target cell death Immunity 2004 21 4 589 601 (Pubitemid 39370513)
148. Zhao D. M., Thornton A. M., DiPaolo R. J., Shevach E. M., Activated CD4+CD25+ T cells selectively kill B lymphocytes Blood 2006 107 10 3925 3932 (Pubitemid 43726798)
149. Hussain S. F., Paterson Y., CD4+CD25+ regulatory T cells that secrete TGF and IL-10 are preferentially induced by a vaccine vector Journal of Immunotherapy 2004 27 5 339 346 (Pubitemid 39121922)
150. Ghiringhelli F., Larmonier N., Schmitt E., Parcellier A., Cathelin D., Garrido C., Chauffert B., Solary E., Bonnotte B., Martin F., CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative European Journal of Immunology 2004 34 2 336 344 (Pubitemid 39255944)
151. Liyanage U. K., Moore T. T., Joo H. G., Tanaka Y., Herrmann V., Doherty G., Drebin J. A., Strasberg S. M., Eberlein T. J., Goedegebuure P. S., Linehan D. C., Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma Journal of Immunology 2002 169 5 2756 2761 (Pubitemid 34921025)
152. Viguier M., Lematre F., Verola O., Cho M. S., Gorochov G., Dubertret L., Bachelez H., Kourilsky P., Ferradini L., Foxp3 expressing CD4+CD25high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells Journal of Immunology 2004 173 2 1444 1453 (Pubitemid 38924326)
153. Griffiths R. W., Elkord E., Gilham D. E., Ramani V., Clarke N., Stern P. L., Hawkins R. E., Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival Cancer Immunology, Immunotherapy 2007 56 11 1743 1753 (Pubitemid 47313079)
154. Colombo M. P., Piconese S., Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy Nature Reviews Cancer 2007 7 11 880 887 (Pubitemid 350006256)
155. Iellem A., Mariani M., Lang R., Recalde H., Panina-Bordignon P., Sinigaglia F., D'Ambrosio D., Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells Journal of Experimental Medicine 2001 194 6 847 853 (Pubitemid 32983019)
156. Vignali D. A. A., Collison L. W., Workman C. J., How regulatory T cells work Nature Reviews Immunology 2008 8 7 523 532
157. Zou L., Barnett B., Safah H., LaRussa V. F., Evdemon-Hogan M., Mottram P., Wei S., David O., Curiel T. J., Zou W., Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals Cancer Research 2004 64 22 8451 8455 (Pubitemid 39491786)
158. Woo E. Y., Chu C. S., Goletz T. J., Schlienger K., Yeh H., Coukos G., Rubin S. C., Kaiser L. R., June C. H., Regulatory CD4+CD25+ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer Cancer Research 2001 61 12 4766 4772 (Pubitemid 32691889)
159. Woo E. Y., Yeh H., Chu C. S., Schlienger K., Carroll R. G., Riley J. L., Kaiser L. R., June C. H., Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation Journal of Immunology 2002 168 9 4272 4276 (Pubitemid 34441324)
160. Nishikawa H., Jger E., Ritter G., Old L. J., Gnjatic S., CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients Blood 2005 106 3 1008 1011 (Pubitemid 41076447)
161. Shimizu J., Yamazaki S., Sakaguchi S., Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity Journal of Immunology 1999 163 10 5211 5218
162. Somasundaram R., Jacob L., Swoboda R., Caputo L., Song H., Basak S., Monos D., Peritt D., Marincola F., Cai D., Birebent B., Bloome E., Kim J., Berencsi K., Mastrangelo M., Herlyn D., Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor- Cancer Research 2002 62 18 5267 5272 (Pubitemid 35024601)
163. Sutmuller R. P. M., van Duivenvoorde L. M., van Elsas A., Schumacher T. N. M., Wildenberg M. E., Allison J. P., Toes R. E. M., Offringa R., Melief C. J. M., Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses Journal of Experimental Medicine 2001 194 6 823 832 (Pubitemid 32983017)
164. Ghiringhelli F., Ménard C., Terme M., Flament C., Taieb J., Chaput N., Puig P. E., Novault S., Escudier B., Vivier E., Lecesne A., Robert C., Blay J. Y., Bernard J., Caillat-Zucman S., Freitas A., Tursz T., Wagner-Ballon O., Capron C., Vainchencker W., Martin F., Zitvogel L., CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor- -dependent manner Journal of Experimental Medicine 2005 202 8 1075 1085 (Pubitemid 41464501)
165. Larmonier N., Cantrell J., LaCasse C., Li G., Janikashvili N., Situ E., Sepassi M., Andreansky S., Katsanis E., Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression Journal of Leukocyte Biology 2008 83 4 1049 1059 (Pubitemid 351959886)
166. Misra N., Bayry J., Lacroix-Desmazes S., Kazatchkine M. D., Kaveri S. V., Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells Journal of Immunology 2004 172 8 4676 4680 (Pubitemid 38456386)
167. Sato K., Tateishi S., Kubo K., Mimura T., Yamamoto K., Kanda H., Downregulation of IL-12 and a novel negative feedback system mediated by CD25+CD4+ T cells Biochemical and Biophysical Research Communications 2005 330 1 226 232 (Pubitemid 40394956)
168. Taams L. S., van Amelsfort J. M. R., Tiemessen M. M., Jacobs K. M. G., de Jong E. C., Akbar A. N., Bijlsma J. W. J., Lafeber F. P. J. G., Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells Human Immunology 2005 66 3 222 230 (Pubitemid 40395242)
169. Prasad S. J., Farrand K. J., Matthews S. A., Chang J. H., McHugh R. S., Ronchese F., Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells Journal of Immunology 2005 174 1 90 98 (Pubitemid 40007395)
170. Yu P., Lee Y., Liu W., Krausz T., Chong A., Schreiber H., Fu Y. X., Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors Journal of Experimental Medicine 2005 201 5 779 791 (Pubitemid 40395122)
171. Larmonier N., Janikashvili N., Lacasse C. J., Larmonier C. B., Cantrell J., Situ E., Lundeen T., Bonnotte B., Katsanis E., Imatinib mesylate inhibits CD4+CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumors Journal of Immunology 2008 181 10 6955 6963
172. El Andaloussi A., Han Y. U., Lesniak M. S., Prolongation of survival following depletion of CD4+CD25 + regulatory T cells in mice with experimental brain tumors Journal of Neurosurgery 2006 105 3 430 437 (Pubitemid 44358755)
173. Comes A., Rosso O., Orengo A. M., di Carlo E., Sorrentino C., Meazza R., Piazza T., Valzasina B., Nanni P., Colombo M. P., Ferrini S., CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine Journal of Immunology 2006 176 3 1750 1758 (Pubitemid 43134320)
174. Attia P., Powell D. J. Jr., Maker A. V., Kreitman R. J., Pastan I., Rosenberg S. A., Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2 Journal of Immunotherapy 2006 29 2 208 214
175. Dannull J., Su Z., Rizzieri D., Yang B. K., Coleman D., Yancey D., Zhang A., Dahm P., Chao N., Gilboa E., Vieweg J., Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells Journal of Clinical Investigation 2005 115 12 3623 3633 (Pubitemid 43121851)
176. Ko K., Yamazaki S., Nakamura K., Nishioka T., Hirota K., Yamaguchi T., Shimizu J., Nomura T., Chiba T., Sakaguchi S., Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells Journal of Experimental Medicine 2005 202 7 885 891 (Pubitemid 41396888)
177. Ramirez-Montagut T., Chow A., Hirschhorn-Cymerman D., Terwey T. H., Kochman A. A., Lu S., Miles R. C., Sakaguchi S., Houghton A. N., Van Den Brink M. R. M., Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity Journal of Immunology 2006 176 11 6434 6442 (Pubitemid 43787825)
178. Read S., Greenwald R., Izcue A., Robinson N., Mandelbrot D., Francisco L., Sharpe A. H., Powrie F., Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo Journal of Immunology 2006 177 7 4376 4383 (Pubitemid 44469766)
179. Quezada S. A., Peggs K. S., Curran M. A., Allison J. P., CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells Journal of Clinical Investigation 2006 116 7 1935 1945 (Pubitemid 44033317)
180. Muller A. J., DuHadaway J. B., Donover P. S., Sutanto-Ward E., Prendergast G. C., Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy Nature Medicine 2005 11 3 312 319 (Pubitemid 40460560)
181. Gorelink L., Flavell R. A., Immune-mediated eradication of tumors through the blockade of transforming growth factor- signaling in T cells Nature Medicine 2001 7 10 1118 1122 (Pubitemid 33010019)
182. Thomas D. A., Massagué J., TGF- directly targets cytotoxic T cell functions during tumor evasion of immune surveillance Cancer Cell 2005 8 5 369 380 (Pubitemid 41579832)
183. Lutsiak M. E. C., Semnani R. T., de Pascalis R., Kashmiri S. V. S., Schlom J., Sabzevari H., Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide Blood 2005 105 7 2862 2868 (Pubitemid 40446280)
184. Taieb J., Chaput N., Schartz N., Roux S., Novault S., Ménard C., Ghiringhelli F., Terme M., Carpentier A. F., Darrasse-Jse G., Lemonnier F., Zitvogel L., Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines Journal of Immunology 2006 176 5 2722 2729
185. Valzasina B., Guiducci C., Dislich H., Killeen N., Weinberg A. D., Colombo M. P., Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR Blood 2005 105 7 2845 2851 (Pubitemid 40446278)
186. Peng G., Guo Z., Kiniwa Y., Voo K. S., Peng W., Fu T., Wang D. Y., Li Y., Wang H. Y., Wang R. F., Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function Science 2005 309 5739 1380 1384 (Pubitemid 41209366)
187. Ghiringhelli F., Menard C., Puig P. E., Ladoire S., Roux S., Martin F., Solary E., le Cesne A., Zitvogel L., Chauffert B., Metronomic cyclophosphamide regimen selectively depletes CD4 +CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients Cancer Immunology, Immunotherapy 2007 56 5 641 648 (Pubitemid 46348738)
188. Motoyoshi Y., Kaminoda K., Saitoh O., Hamasaki K., Nakao K., Ishii N., Nagayama Y., Eguchi K., Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide Oncology Reports 2006 16 1 141 146
189. Audia S., Nicolas A., Cathelin D., Larmonier N., Ferrand C., Foucher P., Fanton A., Bergoin E., Maynadie M., Arnould L., Bateman A., Lorcerie B., Solary E., Chauffert B., Bonnotte B., Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+CD25 + T lymphocytes Clinical and Experimental Immunology 2007 150 3 523 530 (Pubitemid 350098743)
190. Mahnke K., Johnson T. S., Ring S., Enk A. H., Tolerogenic dendritic cells and regulatory T cells: a two-way relationship Journal of Dermatological Science 2007 46 3 159 167 (Pubitemid 46601842)
191. Yamazaki S., Patel M., Harper A., Bonito A., Fukuyama H., Pack M., Tarbell K. V., Talmor M., Ravetch J. V., Inaba K., Steinman R. M., Effective expansion of alloantigen-specific Foxp3+ CD25 + CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction Proceedings of the National Academy of Sciences of the United States of America 2006 103 8 2758 2763
192. Dhodapkar M. V., Steinman R. M., Antigen-bearing immature dendritic cells induce peptide-specific CD8+ regulatory T cells in vivo in humans Blood 2002 100 1 174 177 (Pubitemid 35177444)
193. Sato K., Yamashita N., Baba M., Matsuyama T., Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells Blood 2003 101 9 3581 3589 (Pubitemid 36857945)
194. Gilliet M., Liu Y. J., Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells Journal of Experimental Medicine 2002 195 6 695 704 (Pubitemid 34259715)
195. Wei S., Kryczek I., Zou L., Daniel B., Cheng P., Mottram P., Curiel T., Lange A., Zou W., Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma Cancer Research 2005 65 12 5020 5026 (Pubitemid 40827308)
196. Yamazaki S., Iyoda T., Tarbell K., Olson K., Velinzon K., Inaba K., Steinman R. M., Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells Journal of Experimental Medicine 2003 198 2 235 247 (Pubitemid 37009740)
197. Wakkach A., Fournier N., Brun V., Breittmayer J. P., Cottrez F., Groux H., Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo Immunity 2003 18 5 605 617 (Pubitemid 36588578)
198. Serra P., Amrani A., Yamanouchi J., Han B., Thiessen S., Utsugi T., Verdaguer J., Santamaria P., CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells Immunity 2003 19 6 877 889 (Pubitemid 37542307)
199. Ouabed A., Hubert F. X., Chabannes D., Gautreau L., Heslan M., Josien R., Differential control of T regulatory cell proliferation and suppressive activity by mature plasmacytoid versus conventional spleen dendritic cells Journal of Immunology 2008 180 9 5862 5870
200. Lutz M. B., Schuler G., Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends in Immunology 2002 23 9 445 449 (Pubitemid 35015188)
201. Mahnke K., Enk A. H., Dendritic cells: key cells for the induction of regulatory T cells? Current Topics in Microbiology and Immunology 2005 293 133 150 (Pubitemid 40791228)
202. Verhasselt V., Vosters O., Beuneu C., Nicaise C., Stordeur P., Goldman M., Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells European Journal of Immunology 2004 34 3 762 772 (Pubitemid 39255924)
203. Belkaid Y., Oldenhove G., Tuning microenvironments: induction of regulatory T cells by dendritic cells Immunity 2008 29 3 362 371
204. Langenkamp A., Messi M., Lanzavecchia A., Sallusto F., Kinetics of dendritic cell activation: impact on priming of TH1,TH2 and nonpolarized T cells Nature Immunology 2000 1 4 311 316
205. Munn D. H., Sharma M. D., Lee J. R., Jhaver K. G., Johnson T. S., Keskin D. B., Marshall B., Chandler P., Antonia S. J., Burgess R., Slingluff C. L., Mellor A. L., Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase Science 2002 297 5588 1867 1870 (Pubitemid 35024345)
206. Fallarino F., Grohmann U., Hwang K. W., Orabona C., Vacca C., Bianchi R., Belladonna M. L., Fioretti M. C., Alegre M. L., Puccetti P., Modulation of tryptophan catabolism by regulatory T cells Nature Immunology 2003 4 12 1206 1212 (Pubitemid 37547898)
207. Sharma M. D., Hou D. Y., Liu Y., Koni P. A., Metz R., Chandler P., Mellor A. L., He Y., Munn D. H., Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes Blood 2009 113 24 6102 6111
208. Matta B. M., Castellaneta A., Thomson A. W., Tolerogenic plasmacytoid DC European Journal of Immunology 2010 40 10 2667 2676
209. Belladonna M. L., Grohmann U., Guidetti P., Volpi C., Bianchi R., Fioretti M. C., Schwarcz R., Fallarino F., Puccetti P., Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO Journal of Immunology 2006 177 1 130 137 (Pubitemid 43939124)
210. Fallarino F., Grohmann U., You S., McGrath B. C., Cavener D. R., Vacca C., Orabona C., Bianchi R., Belladonna M. L., Volpi C., Santamaria P., Fioretti M. C., Puccetti P., The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor -chain and induce a regulatory phenotype in naive T cells Journal of Immunology 2006 176 11 6752 6761 (Pubitemid 43787857)
211. Chen W. J., Wahl S. M., TGF- : the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression Cytokine and Growth Factor Reviews 2003 14 2 85 89 (Pubitemid 36389522)
212. Ge W., Ma X., Li X., Wang Y., Li C., Meng H., Liu X., Yu Z., You S., Qiu L., B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells Leukemia Research 2009 33 7 948 957
213. Coyle A. J., Gutierrez-Ramos J. C., The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function Nature Immunology 2001 2 3 203 209 (Pubitemid 33705995)
214. Curiel T. J., Wei S., Dong H., Alvarez X., Cheng P., Mottram P., Krzysiek R., Knutson K. L., Daniel B., Zimmermann M. C., David O., Burow M., Gordon A., Dhurandhar N., Myers L., Berggren R., Hemminki A., Alvarez R. D., Emilie D., Curiel D. T., Chen L., Zou W., Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity Nature Medicine 2003 9 5 562 567 (Pubitemid 36597102)
215. Selenko-Gebauer N., Majdic O., Szekeres A., B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy Journal of Immunology 2003 170 7 3637 3644 (Pubitemid 36359233)
216. Wei S., Kryczek I., Zou W., Regulatory T-cell compartmentalization and trafficking Blood 2006 108 2 426 431 (Pubitemid 44061338)
217. Ishida T., Ishii T., Inagaki A., Yano H., Komatsu H., Iida S., Inagaki H., Ueda R., Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege Cancer Research 2006 66 11 5716 5722 (Pubitemid 43927124)
218. Gobert M., Treilleux I., Bendriss-Vermare N., Bachelot T., Goddard-Leon S., Arfl V., Biota C., Doffin A. C., Durand I., Olive D., Perez S., Pasqual N., Faure C., Ray-Coquard I., Puisieux A., Caux C., Blay J. Y., Méné trier-Caux C., Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical utcome Cancer Research 2009 69 5 2000 2009
219. Godiska R., Chantry D., Raport C. J., Sozzani S., Allavena P., Leviten D., Mantovani A., Gray P. W., Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells Journal of Experimental Medicine 1997 185 9 1595 1604 (Pubitemid 27203256)
220. Vulcano M., Albanesi C., Stoppacciaro A., Bagnati R., D'Amico G., Struyf S., Transidico P., Bonecchi R., Prete A. D., Allavena P., Ruco L. P., Chiabrando C., Girolomoni G., Mantovani A., Sozzani S., Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo European Journal of Immunology 2001 31 3 812 822 (Pubitemid 32241777)
221. Enarsson K., Lundgren A., Kindlund B., Hermansson M., Roncador G., Banham A. H., Lundin B. S., Quiding-Jrbrink M., Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma Clinical Immunology 2006 121 3 358 368 (Pubitemid 44738715)
222. Houot R., Perrot I., Garcia E., Durand I., Lebecque S., Human CD4+CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation Journal of Immunology 2006 176 9 5293 5298
223. Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., Shimizu J., Takahashi T., Nomura T., Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease Immunological Reviews 2006 212 8 27 (Pubitemid 44116697)
224. Kryczek I., Zou L., Rodriguez P., Zhu G., Wei S., Mottram P., Brumlik M., Cheng P., Curiel T., Myers L., Lackner A., Alvarez X., Ochoa A., Chen L., Zou W., B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma Journal of Experimental Medicine 2006 203 4 871 881
225. Suh W. K., Gajewska B. U., Okada H., Gronski M. A., Bertram E. M., Dawicki W., Duncan G. S., Bukczynski J., Plyte S., Elia A., Wakeham A., Itie A., Chung S., Da Costa J., Arya S., Horan T., Campbell P., Gaida K., Ohashi P. S., Watts T. H., Yoshinaga S. K., Bray M. R., Jordana M., Mak T. W., The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses Nature Immunology 2003 4 9 899 906 (Pubitemid 37098661)
226. Kryczek I., Wei S., Zou L., Zhu G., Mottram P., Xu H., Chen L., Zou W., Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells Journal of Immunology 2006 177 1 40 44 (Pubitemid 43939113)
227. Sarris M., Andersen K. G., Randow F., Mayr L., Betz A. G., Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition Immunity 2008 28 3 402 413